Results
190
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
190 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2858 | HK$0.91 | 13.8% | 71.7% | HK$6.1b | HK$1.63 | PE8.2x | E19.6% | 3.2% | Diversified Financials | ||
CKF | AU$8.35 | 10.7% | -25.4% | AU$984.3m | AU$9.89 | PE19.5x | E18.4% | 3.2% | Consumer Services | ||
500265 New | ₹635.95 | 2.7% | -35.3% | ₹85.2b | ₹775.00 | PE10.8x | E4.4% | 1.6% | Materials | ||
EW | ₱9.80 | 0% | 11.4% | ₱22.0b | ₱11.20 | PB0.3x | E4.2% | 5.5% | Banks | ||
HLS | AU$1.36 | -6.2% | -6.9% | AU$983.9m | AU$1.37 | PS0.6x | E96.7% | 0% | Healthcare | ||
MARK | Rp940.00 | -1.6% | 27.0% | Rp3.6t | Rp1,250.00 | PE12.8x | E8.7% | 4.3% | Capital Goods | ||
DM0 | S$0.34 | 0% | 4.7% | S$182.7m | n/a | PE7.9x | n/a | 4.5% | Materials | ||
NIKL | ₱2.60 | 19.8% | -44.4% | ₱36.2b | ₱2.83 | PE13.6x | E2.6% | 7.7% | Materials | ||
2142 New | HK$3.62 | -1.1% | 127.7% | HK$2.7b | n/a | PE16x | n/a | n/a | Pharmaceuticals & Biotech | ||
SIDO New | Rp565.00 | -1.7% | 13.0% | Rp17.0t | Rp726.67 | PE14.8x | E7.2% | 6.4% | Household | ||
SECB | ₱77.25 | 6.6% | 5.5% | ₱58.2b | ₱116.04 | PB0.4x | E16.7% | 3.9% | Banks | ||
DDR | AU$8.35 | -2.9% | -27.2% | AU$1.5b | AU$10.60 | PE18.8x | E9.7% | 5.4% | Tech | ||
BYIT | UK£4.60 | -0.5% | -29.1% | UK£1.1b | UK£6.00 | PE21.4x | E7.2% | 3.9% | Software | ||
ABG | NOK 7.23 | 3.7% | 18.9% | NOK 3.8b | n/a | PE13.1x | n/a | 6.9% | Diversified Financials | ||
FOYRK New | €4.25 | 3.5% | 3.4% | €213.2m | €5.70 | PE8.2x | E7.3% | 2.8% | Retail | ||
CVSG | UK£9.86 | 0.6% | -40.2% | UK£707.4m | UK£14.09 | PE27x | E15.0% | 0.8% | Healthcare | ||
FRAN | UK£1.47 | 4.6% | -10.4% | UK£282.5m | UK£3.23 | PE39.2x | S7.9% | 1.6% | Commercial Services | ||
LOGIST | SEK 150.50 | -1.0% | 25.4% | SEK 1.1b | n/a | PE12.5x | n/a | 3.5% | Real Estate Management and Development | ||
GAMA | UK£13.30 | -0.6% | 12.3% | UK£1.3b | UK£18.54 | PE22.6x | E13.9% | 1.3% | Telecom | ||
FOUR New | UK£56.60 | -6.1% | 4.8% | UK£1.6b | UK£71.98 | PE17.7x | E4.4% | 2.9% | Media | ||
SDY | UK£0.20 | -27.6% | -24.0% | UK£91.7m | UK£0.42 | PS0.2x | E87.5% | 13.1% | Capital Goods | ||
OPT New | UK£1.72 | 15.4% | n/a | UK£152.7m | UK£2.08 | PS1.5x | S7.6% | n/a | Healthcare | ||
CDXC | US$5.52 | -2.0% | 260.8% | US$435.6m | US$7.96 | PE284.6x | E81.8% | n/a | Pharmaceuticals & Biotech | ||
DK | US$18.57 | 4.0% | -34.7% | US$1.2b | US$20.23 | PS0.08x | E57.3% | 5.5% | Energy |